Observing Myopic Patients Undergoing PTK-PRK Treatment with CZM MEL 90 Laser to Check EpiMaster Software Predictions

What this Trial Is About

This research aims to verify the accuracy of the EpiMaster application softwares predictions for post-operative results in patients undergoing PTK-PRK refractive treatments. The study focuses on people with myopic or myopic and astigmatic refractive errors and compares predicted outcomes with actual clinical data after surgery. This observational study does not use the EpiMaster software during treatment but collects data to assess its prediction capabilities. Participants will receive PTK-PRK refractive treatment following routine clinical practice using the CZM MEL 90 Excimer Laser. The study does not involve any experimental procedures or interventions beyond standard care. The aim is to gather postoperative data to evaluate how well the software predicts the refractive outcomes, considering epithelial remodeling. During the study, participants will undergo follow-up visits and examinations as part of their routine care and data collection. Researchers will measure the difference between the spherical equivalent SE measured after surgery and the SE predicted by the EpiMaster software, with the primary outcome assessed at six months post-treatment. Participants need to agree to attend all follow-ups and understand the study information before enrolling. The study is expected to continue until mid-2027.

Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser